Emerging Biopharmaceuticals from Pimpinella Genus

Jiajia Wu,Zhen Cao,Haozhen Zhang,Muhammad Ishaq,Xu Yu,Shikai Yan,Xue Xiao,Hui-Zi Jin,Syed Shams ul Hassan

DOI: https://doi.org/10.3390/molecules28041571

IF: 4.6

2023-02-07

Molecules

Abstract:Evolved over eons to encode biological assays, plants-derived natural products are still the first dawn of drugs. Most researchers have focused on natural compounds derived from commonly used Pimpinella species, such as P. anisum, P. thellungiana, P. saxifrage, and P. brachycarpa, to investigate their antioxidant, antibacterial, and anti-inflammatory properties. Ethnopharmacological studies demonstrated that the genus Pimpinella has the homology characteristics of medicine and food and mainly in the therapy of gastrointestinal dysfunction, respiratory diseases, deworming, and diuresis. The natural product investigation of Pimpinella spp. revealed numerous natural products containing phenylpropanoids, terpenoids, flavonoids, coumarins, sterols, and organic acids. These natural products have the potential to provide future drugs against crucial diseases, such as cancer, hypertension, microbial and insectile infections, and severe inflammations. It is an upcoming field of research to probe a novel and pharmaceutically clinical value on compounds from the genus Pimpinella. In this review, we attempt to summarize the present knowledge on the traditional applications, phytochemistry, and pharmacology of more than twenty-five species of the genus Pimpinella.

chemistry, multidisciplinary,biochemistry & molecular biology